Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Prostatic Neoplasms 30Glioblastoma 28Breast Neoplasms 19Lung Neoplasms 17Carcinoma, Non-Small-Cell Lung 17Oropharyngeal Neoplasms 14Squamous Cell Carcinoma of Head and Neck 11Sarcoma 10Glioma 10Esophageal Neoplasms 10Brain Neoplasms 10Urinary Bladder Neoplasms 9Astrocytoma 9Gliosarcoma 8Triple Negative Breast Neoplasms 7Neoplasm Metastasis 7Mouth Neoplasms 7Uterine Cervical Neoplasms 6Rectal Neoplasms 6Melanoma 6Head and Neck Neoplasms 6Carcinoma, Hepatocellular 6Carcinoma 6Adenocarcinoma Of Esophagus 6Stomach Neoplasms 5Pancreatic Neoplasms 5Neoplasms 5Laryngeal Neoplasms 5Esophageal Squamous Cell Carcinoma 5Carcinoma, Squamous Cell 5

Interventions

Rituximab 45Cyclophosphamide 38ibrutinib 22fludarabine 22acalabrutinib 21venetoclax 20zanubrutinib 17Lenalidomide 17Bendamustine Hydrochloride 17obinutuzumab 16fludarabine phosphate 14Magnetic Resonance Spectroscopy 14Cytarabine 14Specimen Handling 13CT-P10 13pirtobrutinib 12Biopsy 12glofitamab 10Etoposide 10Whole-Body Irradiation 9Vincristine 7Peripheral Blood Stem Cell Transplantation 7Mycophenolic Acid 7Melphalan 7Doxorubicin 7brexucabtagene autoleucel 6Cyclosporine 6orelabrutinib 5Methotrexate 5Immunotherapy, Adoptive 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Mantle-Cell × Radiation × 1 year × Clear all
NCT04054167 2026-06-03

Ultra Low Dose Radiation Delivered Before or After Chemotherapy-Free Targeted Therapy in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
51 enrolled
Lymphoid

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡